Fludarabine- (C2-Methylhydroxyphosphoramide)- [Anti-Igf-1r]: Synthesis and Selectively Targeted Anti-Neoplastic Cytotoxicity Against Pulmonary Adenocarcinoma (A549)

Journal of Pharmaceutics & Drug Delivery Research

doi 10.4172/2325-9604.1000129

Full Text

Abstract

Available in

Date

Authors

Publisher

OMICS Publishing Group

Related search

IGF-1R as an Anti-Cancer Target--Trials and Tribulations

Chinese Journal of Cancer
2013English

Anti-Tumor Activity of CrTX in Human Lung Adenocarcinoma Cell Line A549

Acta Pharmacologica Sinica
MedicinePharmacology
2011English

Icaritin, a Novel FASN Inhibitor, Exerts Anti-Melanoma Activities Through IGF-1R/STAT3 Signaling

Oncotarget
Oncology
2016English

Anti-Igf-1r Monoclonal Antibody Inhibits the Carcinogenicity Activity of Acquired Trastuzumab-Resistant SKOV3

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

In-Vitro Cytotoxicity of Trigona Itama Honey Against Human Lung Adenocarcinoma Epithelial Cell Line (A549)

European Journal of Integrative Medicine
Alternative MedicineComplementary
2019English

Potential Therapeutic Effects of Curcumin, the Anti-Inflammatory Agent, Against Neurodegenerative, Cardiovascular, Pulmonary, Metabolic, Autoimmune and Neoplastic Diseases

International Journal of Biochemistry and Cell Biology
BiochemistryCell Biology
2009English

Efficacy of and Resistance to Anti-Igf-1r Therapies in Ewing's Sarcoma Is Dependent on Insulin Receptor Signaling

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Combinational Therapy Enhances the Effects of Anti-Igf-1r mAb Figitumumab to Target Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2015English

Safety, Tolerability, and Pharmacokinetics of the Anti-Igf-1r Monoclonal Antibody Figitumumab in Patients With Refractory Adrenocortical Carcinoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy